Results 101 to 110 of about 9,359 (237)

Koiran diabetes mellitus ja insuliinin korvaushoito : kirjallisuuskatsaus [PDF]

, 2017
Tämän kirjallisuuskatsauksen tarkoituksena on perehtyä insuliinihormonin toimintaan elimistössä ja diabetes mellituksen patologiaan. Työssä esitellään lisäksi Suomen markkinoilla olevia insuliinivalmisteita ja niiden käyttömahdollisuudet koirien diabetes
Kangas, Heli
core  

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity

Obesity Reviews, Volume 26, Issue 12, December 2025.
ABSTRACT Introduction Although the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to
Sarah Berdot, Germain Perrin, Emmanuel Disse, Armelle Arnoux, Eric Bertin, Anne‐Laure Borel, Marie‐Claude Brindisi, Arnaud De Luca, Edouard‐Jules Laforgue, Jean‐Daniel Lalau, Yann Matussiere, Emilie Montastier, Agnès Sallé, Bérénice Segrestin, Valentine Suteau, French Hospital Expert Panel, Sebastien Czernichow, Brigitte Sabatier   +17 more
wiley   +1 more source

Análisis comparativo de insulina glargina frente a la insulina detemir: un modelo de minimización de costos aplicable en Colombia

Biomédica: revista del Instituto Nacional de Salud, 2015
Introducción. Más del 90 % de los individuos diagnosticados con diabetes mellitus presentan el tipo 2, cuya resistencia periférica a la acción de la insulina es conocida. Objetivo.
Argemiro Fragozo, María Fernanda Puerta, Juan Diego Misas   +2 more
doaj   +1 more source

The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials

Pediatric Diabetes, 2019
Historically, data on the rate of hyperglycemia and ketosis have not been collected in clinical trials. However, it is clinically important to assess the rate of these events in children with type 1 diabetes (T1D).
N. Thalange, L. Deeb, G. Klingensmith, D. Franco, L. Bardtrum, D. Tutkunkardas, T. Danne   +6 more
semanticscholar   +1 more source

Recomendaciones del Grupo GARIN para el manejo de pacientes no críticos con diabetes o hiperglucemia de estrés y nutrición artificial [PDF]

, 2012
Background & aims: By means of this update, the GARIN working group aims to define its position regarding the treatment of patients with diabetes or stress hyperglycaemia and artificial nutrition.
García Almeida, J.M., García Luna, Pedro Pablo, Irles Rocamora, José Antonio, Molina, María José, Muñoz Aguilar, Antonio, Olveira Fuster, Gabriel, Pereira Cunill, José Luis, Rebollo Pérez, Isabel, Serrano Aguayo, Pilar, Tapia Guerrero, María José   +9 more
core  

MJA Practice Essentials - 2: Recent advances in therapy of diabetes - Endocrinology [PDF]

, 2003
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.As suboptimal blood glucose control has a lasting harmful effect even if control improves ...
Chan JL, Jones TW, Moore‐Sullivan TM, The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus, Wang F, Weissberg‐Benchell J, White NH   +6 more
core   +1 more source

Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus [PDF]

, 2013
BACKGROUND: Management of diabetes in elderly subjects is complex and careful management of glucose levels is of particular importance in this population because of an increased risk of diabetes-related complications and hypoglycaemia. OBJECTIVE: The aim
F. Søndergaard, G. Koehler, G. Treiber, H. Haahr, H. Hastrup, J. K. Mader, K. Glettler, M. Urschitz, M. Wolf, S. Deller, S. Korsatko, T. R. Pieber   +11 more
core   +1 more source

Funktionelle Insulintherapie (FIT) beim Typ-1-Diabetes [PDF]

, 2018
Zusammenfassung: Das Ziel der Insulinbehandlung bei Patienten mit Diabetes mellitus Typ 1 besteht darin, eine nahezu normoglykämische Blutzuckereinstellung unter Vermeidung von schweren Hypoglykämien zu erreichen, um einerseits die Entwicklung von mikro-
Lehmann, R., Pavlicek, V.
core  

A Pharmaceutical Innovation – Is it Worth the Money? Whose Money? [PDF]

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance.
Michele Sennhauser, Peter Zweifel
core  

Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis

Therapeutic Advances in Endocrinology and Metabolism, 2018
Background: Diabetes mellitus type 1 (DM1) is an autoimmune disease characterized by metabolic destruction of pancreatic cells responsible for insulin production, with treatment based on replacing insulin.
Thales B C Silva, P. H. R. F. Almeida, V. Araujo, F. Acurcio, A. G. Guerra Júnior, B. Godman, J. Alvares   +6 more
semanticscholar   +1 more source